Repositioning Candidate Details
| Candidate ID: | R0737 |
| Source ID: | DB05205 |
| Source Type: | investigational |
| Compound Type: | small molecule |
| Compound Name: | CX157 |
| Synonyms: | -- |
| Molecular Formula: | -- |
| SMILES: | -- |
| DrugBank Description: | CX157,3-fluoro-7-(2,2,2,-trifluoroethoxy)phenoxathiin-10,10-dioxide, is a reversible, selective inhibitor of MAO-A designed to have improved oral bioavailability and reduced clearance compared to previous MAO-A inhibitors of this class. |
| CAS Number: | -- |
| Molecular Weight: | |
| DrugBank Indication: | Anxiety Disorders I, Depression I |
| DrugBank Pharmacology: | -- |
| DrugBank MoA: | This drug increases the levels of three vital neurotransmitters that affect mood and anxiety: serotonin, norepinephrine and dopamine. |
| Targets: | Amine oxidase [flavin-containing] A |
| Inclusion Criteria: | Indication associated |
